1. Home
  2. QLGN vs TIVC Comparison

QLGN vs TIVC Comparison

Compare QLGN & TIVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • TIVC
  • Stock Information
  • Founded
  • QLGN 1996
  • TIVC 2016
  • Country
  • QLGN United States
  • TIVC United States
  • Employees
  • QLGN N/A
  • TIVC N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • TIVC Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • QLGN Health Care
  • TIVC Health Care
  • Exchange
  • QLGN Nasdaq
  • TIVC Nasdaq
  • Market Cap
  • QLGN 2.4M
  • TIVC 2.1M
  • IPO Year
  • QLGN N/A
  • TIVC 2021
  • Fundamental
  • Price
  • QLGN $3.32
  • TIVC $4.89
  • Analyst Decision
  • QLGN
  • TIVC
  • Analyst Count
  • QLGN 0
  • TIVC 0
  • Target Price
  • QLGN N/A
  • TIVC N/A
  • AVG Volume (30 Days)
  • QLGN 111.5K
  • TIVC 98.8K
  • Earning Date
  • QLGN 04-15-2025
  • TIVC 03-21-2025
  • Dividend Yield
  • QLGN N/A
  • TIVC N/A
  • EPS Growth
  • QLGN N/A
  • TIVC N/A
  • EPS
  • QLGN N/A
  • TIVC N/A
  • Revenue
  • QLGN N/A
  • TIVC $780,000.00
  • Revenue This Year
  • QLGN N/A
  • TIVC N/A
  • Revenue Next Year
  • QLGN N/A
  • TIVC N/A
  • P/E Ratio
  • QLGN N/A
  • TIVC N/A
  • Revenue Growth
  • QLGN N/A
  • TIVC N/A
  • 52 Week Low
  • QLGN $2.96
  • TIVC $2.43
  • 52 Week High
  • QLGN $29.45
  • TIVC $31.45
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 44.88
  • TIVC 58.32
  • Support Level
  • QLGN $3.06
  • TIVC $2.43
  • Resistance Level
  • QLGN $3.78
  • TIVC $3.58
  • Average True Range (ATR)
  • QLGN 0.28
  • TIVC 0.48
  • MACD
  • QLGN 0.03
  • TIVC 0.18
  • Stochastic Oscillator
  • QLGN 19.80
  • TIVC 75.71

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.

About TIVC Tivic Health Systems Inc.

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

Share on Social Networks: